Insiders · ABVC

Shuling Jiang

Director, 10% owner at Abvc Biopharma, Inc. (ABVC) since May 2022

Shuling Jiang has filed 1 insider report with the SEC since July 2022, as director and 10% owner at Abvc Biopharma, Inc. (ABVC). The latest filing, on July 12, 2022, is a Form 3: Shuling Jiang became an insider at Abvc Biopharma, Inc. (ABVC).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Shuling Jiang is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Abvc Biopharma, Inc. logo
ABVC
Abvc Biopharma, Inc.
Director, 10% ownersince May 2022$0.8663Jul 12, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Questions about Shuling Jiang

What is Shuling Jiang's role at Abvc Biopharma, Inc.?
Shuling Jiang reports to the SEC as director and 10% owner at Abvc Biopharma, Inc. (ABVC), according to the latest filing on July 12, 2022.
Has Shuling Jiang bought or sold stock recently?
No open-market purchases or sales by Shuling Jiang are on file.
How do I get alerts when Shuling Jiang files?
Follow Shuling Jiang on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Shuling Jiang (SEC CIK 0001934554). Totals count each trade once, skipping amendments whose original is on file, from Jul 12, 2022 on. View on SEC EDGAR · Get this as JSON